FIGNL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.233400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.040400E-01
Normal-vs-Stage2
5.307400E-01
Normal-vs-Stage3
3.311200E-01
Normal-vs-Stage4
7.278000E-01
Stage1-vs-Stage2
7.760000E-01
Stage1-vs-Stage3
1.477750E-01
Stage1-vs-Stage4
4.951600E-01
Stage2-vs-Stage3
4.915800E-02
Stage2-vs-Stage4
1.476230E-01
Stage3-vs-Stage4
6.802100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.260600E-01
Normal-vs-AfricanAmerican
5.156800E-01
Normal-vs-Asian
4.816000E-01
Caucasian-vs-AfricanAmerican
8.679600E-01
Caucasian-vs-Asian
4.974600E-01
AfricanAmerican-vs-Asian
8.163800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.004000E-01
Normal-vs-Female
5.566600E-01
Male-vs-Female
1.563230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.330600E-01
Normal-vs-Age(41-60Yrs)
5.782400E-01
Normal-vs-Age(61-80Yrs)
4.980200E-01
Normal-vs-Age(81-100Yrs)
5.673400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.099800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.032600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.873400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.590000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.590800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.318200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.437000E-01
Normal-vs-Daily Drinker
4.893400E-01
Normal-vs-Weekly Drinker
5.528200E-01
Normal-vs-Occasional Drinker
5.754000E-01
Normal-vs-Social Drinker
5.999800E-01
Non Drinker-vs-Daily Drinker
5.022600E-01
Non Drinker-vs-Weekly Drinker
1.683970E-01
Non Drinker-vs-Occasional Drinker
4.884000E-02
Non Drinker-vs-Social Drinker
4.728200E-02
Daily Drinker-vs-Weekly Drinker
5.479200E-01
Daily Drinker-vs-Occasional Drinker
3.300800E-01
Daily Drinker-vs-Social Drinker
2.876200E-01
Weekly Drinker-vs-Occasional Drinker
8.043400E-01
Weekly Drinker-vs-Social Drinker
6.855600E-01
Occasional Drinker-vs-Social Drinker
8.198000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.222600E-01
Normal-vs-Grade 2
9.450400E-01
Normal-vs-Grade 3
9.730400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.990600E-01
Grade 1-vs-Grade 3
1.182450E-01
Grade 1-vs-Grade 4
9.222600E-01
Grade 2-vs-Grade 3
7.018400E-02
Grade 2-vs-Grade 4
9.450400E-01
Grade 3-vs-Grade 4
9.730400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.595800E-01
Normal-vs-NonDiabetic
5.216600E-01
Diabetic-vs-NonDiabetic
1.514250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.081600E-01
Normal-vs-NoPancreatitis
5.055000E-01
Pancreatitis-vs-NoPancreatitis
9.680600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.269600E-01
Normal-vs-N1
5.290400E-01
N0-vs-N1
9.463200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.869400E-01
Normal-vs-TP53-NonMutant
5.441000E-01
TP53-Mutant-vs-TP53-NonMutant
4.877200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
